Molecular ontogeny of the human antibody repertoire to the Haemophilus influenzae type B polysaccharide: expression of canonical variable regions and their variants in vaccinated infants.
A structurally conserved antibody combining site, encoded by the IGH V3-23 and kappa A2 variable (V) region gene segments, predominates the adult immune response to the Haemophilus influenzae type b (Hib) capsular polysaccharide (PS). This site has been elevated to canonical status based upon its relative molecular uniformity and prevalence in adults. To date, no studies have examined the primary structure of Hib PS-specific antibodies in young infants, who are the primary targets of Hib vaccination. In this study we show that canonical Hib PS-specific heavy (H) and light (L) chain V regions are present in 4-month-old infants following two vaccinations with Hib PS-protein conjugates. The infant V regions contain sequence polymorphisms that resemble those found in adult antibodies, as well as polymorphisms at position 95a of the A2 L chain not previously observed in adults. In vitro studies of Fab fragments and recombinant IgG2 antibodies using these V regions identify sequence polymorphisms that impact Hib PS binding affinity and bactericidal activity. These results demonstrate the establishment of canonical V regions in early ontogeny and provide a structural explanation of how canonical antibodies in the infant can vary in their affinity and protective activity against Hib.
Lucas
Alexander H
AH
Children's Hospital Oakland Research Institute, Oakland, CA 94609, USA. alucas@chori.org
McLean
Gary R
GR
Reason
Donald C
DC
O'Connor
Adam P
AP
Felton
Mistique C
MC
Moulton
Karen D
KD
D000595:Amino Acid Sequence; D000888:Antibodies, Anti-Idiotypic / Q000097:blood / Q000276:immunology; D000907:Antibodies, Bacterial / Q000097:blood / Q000235:genetics*; D001426:Bacterial Proteins / Q000008:administration & dosage / Q000276:immunology; D001483:Base Sequence; D006192:Haemophilus Infections / Q000097:blood / Q000517:prevention & control*; D018073:Haemophilus Vaccines / Q000008:administration & dosage / Q000276:immunology*; D019741:Haemophilus influenzae type b / Q000276:immunology*; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000235:genetics; D007143:Immunoglobulin Heavy Chains / Q000235:genetics; D007147:Immunoglobulin Light Chains / Q000235:genetics; D007135:Immunoglobulin Variable Region / Q000097:blood / Q000235:genetics*; D007223:Infant; D008969:Molecular Sequence Data; D011110:Polymorphism, Genetic; D011135:Polysaccharides, Bacterial / Q000008:administration & dosage / Q000276:immunology*; D012689:Sequence Homology, Nucleic Acid; D014611:Vaccination; D014614:Vaccines, Synthetic
D000888:Antibodies, Anti-Idiotypic; D000907:Antibodies, Bacterial; D001426:Bacterial Proteins; D018073:Haemophilus Vaccines; D007140:Immunoglobulin Fab Fragments; D007143:Immunoglobulin Heavy Chains; D007147:Immunoglobulin Light Chains; D007135:Immunoglobulin Variable Region; D011135:Polysaccharides, Bacterial; D014614:Vaccines, Synthetic; C061963:HibTITER protein, Haemophilus influenzae